SEP reports nine months net profit of $2.97 billion

November 15, 2024

Seprod Limited (SEP)

Unaudited financials for the nine months ended September 30, 2024:

Seprod Limited (SEP) for the nine months ended September 30, 2024, reported a 14% increase in Revenue totalling $93.43 billion compared to $82.20 billion in the corresponding period last year. Revenue for the third quarter had a 27% increase to close at $35.10 billion compared to $27.75 billion for the comparable quarter of 2023.

Cost of Sales amounted to $68.71 billion (2023: $61.34 billion), this represents an increase of 12% year over year. Consequently, gross profit increased by 19% to $24.72 billion compared to $20.86 billion for the nine months ended September 30, 2023. The company booked gross profit of $9.80 billion for the third quarter versus $7.04 billion reported for the similar quarter of 2023.

Finance & Other Operating Income decreased by 13% to close at $949.36 million (2023: $1.09 billion). Additionally, operating profit for the nine months ended September 30, 2024, amounted to $7.08 billion, a 3% increase relative to $6.88 billion reported in 2023.

Finance Costs for the nine months ended September 30, 2024, had a 23% increase to reach $2.94 billion (2023: $2.39 billion).

Share of Results of associate & joint venture for the nine months ended September 30, 2024, amounted to $292.52 million, a 65% increase relative to $177.33 million reported in 2023. Share of Results of associate & joint venture for the third quarter amounted to $72.47 million (2023: $40.93 million). Profit Before Taxation totalled $4.44 billion a 5% decrease from the corresponding period last year. (2023: $4.66 billion).

Taxation for the nine months ended September 30, 2024, amounted to $1.40 billion, a 29% increase relative to $1.09 billion reported in 2023. Taxation for the third quarter amounted to $436.07 million (2023: $431.21 million).

Net Profit from Continuing Operations for the nine months ended September 30, 2024, had a 15% decrease to reach $3.03 billion (2023: $3.57 billion). Net Loss for the period from discontinued operation for the nine months amounted to $59.83 million, a 30% increase from the $46.15 million reported in 2023. For the third quarter, Net Loss for the period from discontinued operation was $18.68 million (2023: $23.11 million).

Net Profit for the nine months ended September 30, 2024, had a 16% decrease to reach $2.98 billion (2023: $3.52 billion). For the third quarter, Net Profit for the quarter was $827.65 million (2023: $981.66 million).

Net profit attributable to shareholders for the nine months ended September 30, 2024, amounted to $2.42 billion, a 5% decrease relative to $2.55 billion reported in 2023. For the third quarter, Net profit attributable to shareholders was $653.84 million (2023: $667.55 million).

Consequently, Earnings Per Share for the nine months amounted to $3.29 (2023: EPS: $3.48), while Earnings Per Share for the quarter totaled $0.89 (2023: EPS: $0.91). The twelve-month trailing EPS was $3.74, and the number of shares used in these calculations was 733,546,855.

Notably, SEP’s stock price closed the trading period on November 14, 2024, at a price of $84.43 with a corresponding P/E ratio of 22.57x.

Balance Sheet Highlights:

The company’s assets totalled $121.32 billion (2023: $93.49 billion). This increase was attributable to ‘Property, Plant and Equipment’, which amounted to $29.34 billion (2023: $21.12 billion). ‘Receivables’, also contributed to the increase equating to $28.75 billion (2023: $20.10 billion).

Shareholder’s equity was $29.74 billion (2023: $26.71 billion), representing a book value per share of $40.54 (2023: $36.41).

 

Disclaimer:

Analyst Certification – The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.

Company Disclosure – The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.

2024-11-15T13:01:08-05:00